| Filed On | Filing |
|---|---|
| 13 Nov 2026 | SCHEDULE 13G |
| 10 Nov 2026 |
Form 4: Thingelstad Jamie, EVP, Chief Technology Officer
Received 11,196 shares by exercise or conversion ($630K) · Sold 11,196 shares ($913K) |
| 06 Nov 2026 | 144 |
| 05 Nov 2026 |
Form 4: Reaume Marty M, Director
Received 4,536 shares by exercise or conversion ($268K) · Sold 4,536 shares ($394K) |
| 03 Nov 2026 | 144 |
| 29 Oct 2026 | 10-Q |
| 29 Oct 2026 |
8-K: Results of Operations and Financial Condition
Company advances agentic strategy while driving margin expansion |
| 14 Aug 2026 | SCHEDULE 13G |
| 30 Jul 2026 | 10-Q |
| 30 Jul 2026 |
8-K: Results of Operations and Financial Condition
Second quarter 2026 revenue and Adjusted EBITDA exceed high end of guidance range |
| 21 Jul 2026 | 10-Q/A |
| 29 Jun 2026 | 11-K |
| 02 Jun 2026 | 144 |
| 01 Jun 2026 |
Form 4: Gaurav Razat, Director
Received 3,736 shares as a grant or award |
| 01 Jun 2026 |
Form 4: McConnell Michael J, Director
Received 3,736 shares as a grant or award |
| 01 Jun 2026 |
Form 4: Partin Mark, Director
Received 3,736 shares as a grant or award |
| 01 Jun 2026 |
Form 4: Reaume Marty M, Director
Received 3,736 shares as a grant or award |
| 01 Jun 2026 |
Form 4: Reller Tami, Director
Received 3,736 shares as a grant or award |
| 01 Jun 2026 |
Form 4: Soran Philip, Director
Received 3,736 shares as a grant or award |
| 01 Jun 2026 |
Form 4: Chima Fumbi F., Director
Received 3,736 shares as a grant or award |
Loading...